From a plan-manager perspective, eight per cent of plan members are living with diabetes, said Dr. Bruce Perkins, professor in the division of endocrinology and metabolism at the University of Toronto, during Benefits Canada’s Face to Face Drug Plan Management Forum on Dec. 9, 2020. He said risk-factor management is necessary when it comes to […]
Plan sponsors have to move beyond benefits plan reporting and dig into analytics to better understand medication non-adherence and the top disease states affecting their workforces. “Leveraging plan-specific data can help answer the fundamental questions needed to manage your benefits program,” said Shawn O’Brien, Telus Health’s principal of data enablement and drug, health, dental product roadmaps, during a session at Benefits […]
Toronto-based disease prevention technology company Newtopia Inc. is introducing a product suite aimed at preventing, reversing and slowing the progression of three chronic conditions. Targeting plan members of employer-sponsored health plans, the tools aim to assist users with hypertension, type 2 diabetes and weight management. They combine human interaction, virtual care, digital tools and data science to deliver personalized […]
On May 21, Benefits Canada hosted a webinar to explore the coronavirus pandemic’s impact on chronic disease in the workplace, as well as how virtual solutions can support employee health through this unprecedented time. All employers are currently facing the same concerns, said Marie-Josée Le Blanc, a partner at Mercer, during the webinar. Pointing to the 2019 […]
On May 12, Benefits Canada hosted a webinar to discuss the pharmaceutical industry’s efforts during the coronavirus crisis, as well as some key policy issues for Canadian insurers and their potential impact from the private-payer perspective. Since the end of April, 139 coronavirus treatments have been under investigation and Health Canada has approved several clinical trials […]
Private drug plans saw a slight uptick in costs in 2019 due to the increased use of specialty drugs and higher price points for traditional medications, according to Express Scripts Canada’s annual drug trends report. The report found private drug plan spending per claimant increased one per cent over 2018’s figures. Plans’ annual spend per claimant on […]
Employers should be closely examining the underlying drivers of cost growth in their drug plans, according to a new report by Innovative Medicines Canada. “Typically, [plan sponsors] get their report at the end of the year, they’ll see a cost for their drug plan and they don’t know what’s driving it,” says Joe Farago, the […]
Mental health is the third largest health spend in terms of benefits plan management, according to Derek Weir, manager of health benefit solutions at Medavie Blue Cross. “Fifty-three per cent of Canadians consider anxiety and depression ‘epidemic’ in Canada and 85 per cent say mental-health services are among the most underfunded in health care,” he said […]
Looking ahead to 2020, the big story for health benefits is often avoided because it isn’t easy to address. It’s the elephant in the room. Over the past year, there’s been no shortage of momentum in new and emerging product offerings in the health benefits space — everything from digital cognitive behavioural therapy to virtual […]
When it came to asking his employer to add continuous glucose monitoring to its benefits package, John Whitehead, a level-two food server at Niagara Casinos, went all in. He’s had type 1 diabetes for years, and lived through many technological developments to help manage his condition. While he says blood glucose monitoring represented a major improvement, it […]